Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. - Yankelevich M; Thakur A; Modak S; Chu R; Taub J; Martin A; Schalk D; Schienshang A; Whitaker S; Rea K; Lee DW; Liu Q; et al. (Journal for immunotherapy of cancer, 2024)